Management of bleeding emergencies: when to use recombinant activated Factor VII-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of bleeding emergencies: when to use recombinant activated Factor VII

Published:2005-12-22 Issue:1 Volume:7 Page:25-34
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

DeLoughery Thomas G

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.7.1.25

Reference147 articles.

1. Recombinant Factor VIIa Is a Pan-hemostatic Agent?

2. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review

3. ENOMOTO TM, THORBORG P: Emerging off-label uses for recombinant activated factor VII: grading the evidence. Crit. Care Clin. (2005) 21(3):611-632.

4. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors

5. Recombinant Factor VIIa: clinical applications for an intravenous hemostatic agent with broad-spectrum potential

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postpartum purpura fulminans;Reviews in Vascular Medicine;2017-06

2. Blutgerinnung;Repetitorium Intensivmedizin;2014

3. Traumatologie;Anästhesie;2013

4. Blutgerinnung;Repetitorium Intensivmedizin;2011

5. Management of Acquired Bleeding Problems in Cancer Patients;Hematology/Oncology Clinics of North America;2010-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3